Cargando…

Resveratrol Reverses Functional Chagas Heart Disease in Mice

Chronic chagasic cardiomyopathy (CCC) develops years after acute infection by Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of parasite burden. During disease, the heart undergoes oxidative stress, a potential causative factor for arrhythmias and contractile dy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilar-Pereira, Glaucia, Carneiro, Vitor C., Mata-Santos, Hilton, Vicentino, Amanda R. R., Ramos, Isalira P., Giarola, Naira L. L., Feijó, Daniel F., Meyer-Fernandes, José R., Paula-Neto, Heitor A., Medei, Emiliano, Bozza, Marcelo T., Lannes-Vieira, Joseli, Paiva, Claudia N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082855/ https://www.ncbi.nlm.nih.gov/pubmed/27788262 http://dx.doi.org/10.1371/journal.ppat.1005947

Ejemplares similares

IL-1β is not critical to chronic heart dysfunction in mice with Chagas disease
por: Sousa Oliveira, Camila Victória, et al.
Publicado: (2022)

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2015)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy
por: Gibaldi, Daniel, et al.
Publicado: (2020)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2021)

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach(*)
por: Lannes-Vieira, Joseli
Publicado: (2022)

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart
por: Paiva, Claudia N., et al.
Publicado: (2018)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
por: Oliveira, Ana Carolina, et al.
Publicado: (2023)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
por: Imperador, Carlos Henrique Lima, et al.
Publicado: (2022)

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease
por: Nisimura, Lindice Mitie, et al.
Publicado: (2023)

“Chagas Express XXI”: A new ArtScience social technology for health and science education—A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases
por: Araujo-Jorge, Tania C., et al.
Publicado: (2021)

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease
por: Castro, Julia T., et al.
Publicado: (2023)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
por: Alvarado-Arnez, Lucia Elena, et al.
Publicado: (2018)

Influence of Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism in Progression of Chagas Heart Disease
por: Alves, Silvia Marinho Martins, et al.
Publicado: (2020)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Insights from the use of erythropoietin in experimental Chagas disease
por: de Castro Nobre, Ana Carolina, et al.
Publicado: (2022)

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

MIF Participates in Toxoplasma gondii-Induced Pathology Following Oral Infection
por: Cavalcanti, Marta G., et al.
Publicado: (2011)

MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes
por: Navarro, Isabela Cunha, et al.
Publicado: (2015)

Interleukin-32γ in the Control of Acute Experimental Chagas Disease
por: Braga, Yarlla L. L., et al.
Publicado: (2022)

Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response
por: Muniz, Valdirene S., et al.
Publicado: (2015)

Current trends in the pharmacological management of Chagas disease
por: Ribeiro, Vanessa, et al.
Publicado: (2019)

Long-term Survival Following Heart Transplantation for Chagas Versus Non-Chagas Cardiomyopathy: A Single-center Experience in Northeastern Brazil Over 2 Decades
por: Vieira, Jefferson L., et al.
Publicado: (2022)

Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

The challenge of risk assessment in the riddle of Chagas heart disease
por: Marin-Neto, José Antonio, et al.
Publicado: (2022)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
por: Sampaio, Elieusa e Silva, et al.
Publicado: (2018)

Venom alkaloids against Chagas disease parasite: search for effective therapies
por: Silva, Rafael C. M. Costa, et al.
Publicado: (2020)

Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_apok4a1jeb7c4b5jlessrkbroj